Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients

Thrombosis Journal

Volumn 5, Issue , 2007, Pages

  Moore, Gary W ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ECARIN; LUPUS ANTICOAGULANT; SNAKE VENOM;

ANTIBODY DETECTION; ANTICOAGULANT THERAPY; ARTICLE; BIOASSAY; BLOOD SAMPLING; CONTROLLED STUDY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; RELIABILITY; SCREENING TEST;

EID: 34948872548     PISSN: None     EISSN: 14779560     Source Type: Journal    
DOI: 10.1186/1477-9560-5-12     Document Type: Article

References (20)

1. Arnout J Antiphospholipid syndrome: Diagnostic aspects of lupus anticoagulants Thromb Haemost 2001, 86:83-91. 11487046
2. Bick RL The antiphospholipid thrombosis syndromes: A common multidisciplinary medical problem Clin Appl Thrombosis/Haemostasis 1997, 3:270-83.
3. Triplett DA New diagnostic strategies for lupus anticoagulants and antiphospholipid antibodies Haemostasis 1994, 24:155-64. 7988945
4. Greaves M Cohen H Machin SJ Mackie I Guidelines on the investigation and management of the antiphospholipid syndrome Br J Haematol 2000, 109:704-15. 10.1046/j.1365-2141.2000.02069.x 10929019
5. Brandt JT Triplett DA Alving B Scharrer I Criteria for the diagnosis of lupus anticoagulants: An update Thromb Haemost 1995, 74:1185-90. 8560433
6. Triplett DA Frequent difficulties encountered in the laboratory diagnosis of antiphospholipid-protein antibodies Ann Med Interne 1996, 147(suppl 1):5-9.
7. Jennings I Kitchen S Woods TAL Preston FE Greaves M Potentially clinically important inaccuracies in testing for the lupus anticoagulant: An analysis of results from three surveys of the UK national external quality control scheme (NEQAS) for blood coagulation Thromb Haemost 1997, 77:934-37. 9184405
8. Moore GW Savidge GF The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied Thromb Res 2006, 118:523-528. 10.1016/j.thromres.2005.09.010 16263154
9. Moore GW Smith MP Savidge GF The Ecarin time is an improved confirmatory test for the Taipan snake venom time in warfarinised patients with lupus anticoagulants Blood Coagul Fibrinolysis 2003, 14:307-312. 10.1097/ 00001721-200304000-00015 12695757
10. Machin SJ Giddings JC Greaves M Hutton RA Mackie IJ Malia RG Taberner DA Guidelines on testing for the lupus anticoagulant J Clin Pathol 1991, 44:885-89. 496623 1752976 10.1136/jcp.44.5.440-a
11. Gardiner C Mackie IJ Malia RG Jones DW Winter M Leeming D Taberner DA The importance of locally derived reference ranges and standardised calculation of dilute Russell's viper venom time results in screening for lupus anticoagulant Br J Haematol 2000, 111:1230-1235. 10.1046/ j.1365-2141.2000.02466.x 11167766
12. Cumming AM Jones GR Wensley RT Cundall RB In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: An assessment of four heparin antagonists and two anion exchange resins Thromb Res 1986, 41:43-56. 10.1016/0049-3848(86)90278-1 3961726
13. Jennings I Greaves M Mackie IJ Kitchen S Woods TAL Preston FE Lupus anticoagulant testing: Improvements in performance in a UK NEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods Br J Haematol 2002, 119:364-369. 10.1046/ j.1365-2141.2002.03821.x 12406070
14. Lawrie AS Mackie IJ Purdy G Machin SJ The sensitivity and specificity of commercial reagents for the detection of lupus anticoagulant show marked differences in performance between photo-optical and mechanical coagulometers Thromb Haemost 1999, 81:758-62. 10365750
15. Triplett DA Use of the dilute Russell Viper venom time (dRVVT): Its importance and pitfalls J Autoimmun 2000, 15:173-178. 10.1006/ jaut.2000.0414 10968905
16. Jouhikainen T Detection of lupus anticoagulant by means of dilute Russell's viper venom time is affected by oral anticoagulant therapy Blood Coagul Fibrinolysis 1990, 1:627-632. 2133242
17. Moore GW Savidge GF Smith MP Improved detection of lupus anticoagulants by the dilute Russell's Viper venom time Blood Coagul Fibrinolysis 2000, 11:767-74. 10.1097/00001721-200012000-00011 11132656
18. Stevenson KJ Sneddon JM The role of lipids in the detection of lupus anticoagulant by the dilute Russell Viper venom test: Are platelets or reagents containing hexagonal HII phases necessary? Br J Haematol 1994, 86:583-589. 8043440
19. Miyakis S Lockshin MD Atsumi T Branch DW Brey RL Cervera R Derksen RH De Groot PG Koike T Meroni PL Reber G Shoenfeld Y Tincani A Vlachoyiannopoulos PG Krilis SA International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) J Thromb Haemost 2006, 4:295-306. 10.1111/ j.1538-7836.2006.01753.x 16420554
20. Moore GW Kamat AV Gurney DA O'Connor O Rangarajan S Carr R Savidge GF Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma Clin Lab Haem 2004, 26:429-434. 10.1111/j.1365-2257.2004.00644.x